Hotline:
+ 49 (0) 2204 2918806

Market studies for category Dentistry/Oral

Items 1 to 10 of 59 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  1. Net price*
    Year
  2. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Oryzon Genomics S.A. - Product Pipeline Review - 2013

    Global Markets Direct
    38 pages
    Global Market Direct’s pharmaceuticals report, “Oryzon Genomics S.A. - Product Pipeline Review - 2013” provides data on the Oryzon Genomics S.A.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This
    Englisch | Zukunftsanalyse | SKU: 344521
  3. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Deglutition Disorders Global Clinical Trials Review, H1, 2013

    GlobalData
    51 pages
    Introduction GlobalData's clinical trial report, “Deglutition Disorders Global Clinical Trials Review, H1, 2013" provides data on the Deglutition Disorders clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Deglutition Disorders. It includes an overview of the trial numbers an
    Englisch | Report | SKU: 330463
  4. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Baxter International Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    73 pages
    Global Market Direct’s pharmaceuticals report, “Baxter International Inc. - Product Pipeline Review - 2013” provides data on the Baxter International Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant proje
    Englisch | Zukunftsanalyse | SKU: 344526
  5. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Central Nervous System (CNS) Tumor - Pipeline Review, H1 2013

    Global Markets Direct
    482 pages
    Global Markets Direct’s, 'Central Nervous System (CNS) Tumor - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Central Nervous System (CNS) Tumor, complete with latest updates, and special features on late-stage and discontinu
    Englisch | Zukunftsanalyse | SKU: 344498
  6. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2013

    Global Markets Direct
    37 pages
    Global Market Direct’s pharmaceuticals report, “Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2013” provides data on the Cancer Therapeutics CRC Pty Ltd’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and d
    Englisch | Zukunftsanalyse | SKU: 344531
  7. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Lymphoblastic Lymphoma - Pipeline Review, H1 2013

    Global Markets Direct
    31 pages
    Global Markets Direct’s, 'Lymphoblastic Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Lymphoblastic Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also rev
    Englisch | Zukunftsanalyse | SKU: 344504
  8. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Angelini Group - Product Pipeline Review - 2013

    Global Markets Direct
    35 pages
    Global Market Direct’s pharmaceuticals report, “Angelini Group - Product Pipeline Review - 2013” provides data on the Angelini Group’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is bu
    Englisch | Zukunftsanalyse | SKU: 344536
  9. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2013

    Global Markets Direct
    26 pages
    Global Markets Direct’s, 'Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Juvenile Macular Degeneration (Stargardt Disease), complete with latest updates, and special feature
    Englisch | Zukunftsanalyse | SKU: 344509
  10. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Recordati S.p.A. - Product Pipeline Review - 2013

    Global Markets Direct
    42 pages
    Global Market Direct’s pharmaceuticals report, “Recordati S.p.A. - Product Pipeline Review - 2013” provides data on the Recordati S.p.A.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report i
    Englisch | Zukunftsanalyse | SKU: 344541
  11. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Kyorin Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013

    Global Markets Direct
    50 pages
    Global Market Direct’s pharmaceuticals report, “Kyorin Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013” provides data on the Kyorin Pharmaceutical Co., Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and d
    Englisch | Zukunftsanalyse | SKU: 344514

Items 1 to 10 of 59 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6